Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C

C. HÉZODE ; F. ROUDOT-THORAVAL ; S. NGUYEN ; P. GRENARD ; B. JULIEN ; E. S. ZAFRANI ; J. M. PAWLOTSKY ; D. DHUMEAUX ; S. LOTERSZTAJN ; A. MALLAT | 2006
Périodique

Cannabinoids present in Cannabis sativa (marijuana) exert biological effects via cannabinoid receptors CB1 and CB2. We recently demonstrated that CB1 and CB2 receptors regulate progression of experimental liver fibrosis. We therefore investigate[...]

Plus d'info

Ajouter à la sélection

A retrospective chart review comparing Tiagabine and benzodiazepines for the treatment of alcohol withdrawal

MYRICK H. ; B. TAYLOR ; S. D. LaROWE ; S. NGUYEN ; BOYLE E. ; COCHRAN K. ; R. MALCOLM | 2005
Dans Journal of Psychoactive Drugs (Vol.37 n°4, 2005) Article : Périodique

ENGLISH : Although benzodiazepines are the standard of care in the treatment of alcohol withdrawal, several studies have suggested that anticonvulsants may be equally effective at alleviating alcohol withdrawal symptoms and may pose less of a [...]

Plus d'info

Ajouter à la sélection